CRP and rheumatoid arthritis: Administration of anti‐TNF has been observed to result in the reduction of acute‐phase proteins, including CRP, serum amyloid A, haptoglobin, and fibrinogen, which are elevated in patients with rheumatoid arthritis (RA).28